Cardiac amyloidosis: Shifting our impressions to hopeful

被引：9

作者：

Sawyer D.B. ^{[1
]}

Skinner M. ^{[1
]}

机构：

[1] Amyloid Treatment and Research Program, Boston University School of Medicine, Boston, MA 02118

来源：

Current Heart Failure Reports | 2006年 / 3卷 / 2期

关键词：

Amyloidosis; Symptomatic Heart Failure; Transthyretin; Cardiac Amyloidosis; Free Light Chain;

D O I：

10.1007/s11897-006-0004-z

中图分类号：

学科分类号：

摘要：

Cardiac amyloidosis is a well-known but clinically rare cause of heart failure that has historically been associated with a poor prognosis. Cardiac amyloidosis involves fibril formation from one of several underlying conditions, and the course of illness and prognosis varies among these conditions. Evolving treatment strategies for patients with primary systemic amyloidosis have given this subset of cardiac amyloidosis patients a cause for hope. The identification and appropriate referral of patients in whom this condition is suspected will help to improve the likelihood of successful therapy and long-term survival. Copyright © 2006 by Current Science Inc.

引用

页码：64 / 71

页数：7

共 41 条

[1]

Falk R.H., Diagnosis and management of the cardiac amyloidoses, Circulation, 112, pp. 2047-2060, (2005)

[2]

Hassan W., Al-Sergani H., Mourad W., Tabbaa R., Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management, Tex Heart Inst J, 32, pp. 178-184, (2005)

[3]

O'Hara C.J., Falk R.H., The diagnosis and typing of cardiac amyloidosis, Amyloid, 10, pp. 127-129, (2003)

[4]

Merlini G., Bellotti V., Molecular mechanisms of amyloidosis, N Engl J Med, 349, pp. 583-596, (2003)

[5]

Smith T.J., Kyle R.A., Lie J.T., Clinical significance of histopathologic patterns of cardiac amyloidosis, Mayo Clin Proc, 59, pp. 547-555, (1984)

[6]

Mueller P.S., Edwards W.D., Gertz M.A., Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis, Am J Med, 109, pp. 181-188, (2000)

[7]

Dubrey S.W., Cha K., Skinner M., Et al., Familial and primary (AL) cardiac amyloidosis: Echocardiographically similar diseases with distinctly different clinical outcomes, Heart, 78, pp. 74-82, (1997)

[8]

Liao R., Jain M., Teller P., Et al., Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts, Circulation, 104, pp. 1594-1597, (2001)

[9]

Brenner D.A., Jain M., Pimentel D.R., Et al., Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress, Circ Res, 94, pp. 1008-1010, (2004)

[10]

Dubrey S., Mendes L., Skinner M., Falk R.H., Resolution of heart failure in patients with AL amyloidosis, Ann Intern Med, 125, pp. 481-484, (1996)

← 1 2 3 4 5 →